MATERIALS AND METHoDS
After obtaining approval from the Ethics Committee of Royal Perth Hospital (107/2012), the ICU data of all the patients admitted to the ICU of Royal Perth Hospital between January 2009 and March 2010 were linked to the laboratory databases and death registry. The ICU database contained comprehensive clinical data on severity of acute illness including Acute Physiology and Chronic Health Evaluation (APACHE) II score and its derived predicted mortality, daily Sequential organ Failure Assessment scores 21, 22 , principal and secondary admission diagnoses coded according to the APACHE model and International Classification of Diseases codes, comorbidity, re-admission status, and outcomes after ICU discharge. Royal Perth Hospital is an 800-bed tertiary teaching hospital and the 23-bed multidisciplinary ICU admits about 1500 critically ill adult patients per annum from all specialties, including multiple trauma, burns, cardiothoracic surgery and heart-lung transplantation. All results analysed were performed for clinical purposes and were subsequently retrieved for this study.
The clinical predictors analysed in this study included age, sex, nocturnal discharge (6.00 pm-8.00 am), neutrophil and eosinophil counts on the day of ICU discharge, C-reactive protein (CRP) concentrations on the day of ICU discharge, elective surgical admission, chronic medical diseases as defined by the APACHE prognostic model, APACHE II score and its derived predicted mortality, and maximum and discharge Sequential organ Failure Assessment scores 21, 22 . Serum CRP concentrations were measured by an immunoenzyme analyser (Hitachi 917, Tokyo, Japan) and eosinophil counts were determined by an automated method (Cell-Dyn Sapphire, Abbott Diagnostics, IL, USA) with minimal measurable eosinophil counts of 0.01×10 9 /l (10 cells/ mm 3 ) 18, 23 . The slope, y-intercept and correlation between eosinophil counts measured by this device and manual differential study are 1.000 (95% confidence interval [CI] 0.920-1.040), 0.100 (95% CI 0.100-0.200) and 0.950, respectively 24 . Eosinophil counts <0.01×10 9 /l were not measurable by this automated method and were defined as eosinopenia in this study. For patients who were re-admitted to the ICU during the same hospitalisation, only data from the first ICU admission and at first ICU discharge were used. Unexpected ICU re-admission was defined as re-admission of those patients who were discharged from ICU without a plan to be readmitted after elective surgery. We included all unexpected ICU re-admissions after the first ICU discharge to increase the power of the study. As for survival after hospital discharge, the date of censor for survival was 31 october 2011 and post-ICU mortality was defined by death at any time between ICU discharge and date of censor, independent of hospital stay. No patients were lost to follow-up or had missing mortality data and the median followup time for survival was 26 months (interquartile range [22] [23] [24] [25] [26] [27] [28] [29] [30] . The venous thromboembolism data in relation to presence of thrombocytosis of this cohort of patients were described in our recent publication 25 .
Statistical analysis
The associations between unplanned ICU re-admission during the same hospitalisation or mortality after ICU discharge and eosinopenia were tested with univariate analyses followed by multivariate analysis. Categorical variables and continuous variables with skewed distributions were analysed using chi-square and Mann-Whitney tests, respectively. Logistic regression was used to assess the relationship between eosinopenia and risk of ICU re-admission during the same hospitalisation, after adjusting for known risk factors for unplanned ICU re-admission 5 . Cox proportional hazards regression was used to assess whether eosinopenia at ICU discharge was associated with an increased risk of subsequent unexpected mortality, after confirming the proportionality assumption of eosinopenia for mortality.
Multicollinearity between continuous predictors were excluded, by Pearson's correlation coefficient <0.8, before these predictors were entered into the multivariate Cox and logistic models. During the modelling process, no predictors were removed. Because CRP concentrations within 24 hours of ICU discharge were available only in 755 (52%) patients, CRP was only added to the final multivariate model as a sensitivity analysis to assess whether CRP would change the direction and magnitude of the associations between eosinopenia and adverse outcomes after ICU discharge.
In a separate logistic regression analysis, we also modelled the relationship between eosinophil counts as a continuous variable, and risk of a composite outcome of either unplanned ICU re-admission or post-ICU mortality using a three-knot restricted cubic spline function 26 . This was performed to assess whether eosinophil counts at ICU discharge had a non-linear relationship with either of the adverse outcomes after discharge. The relative importance of each predictor in explaining the variability in survival after ICU discharge was assessed using the chi-square statistic minus the degrees of freedom 25 . In this study a P value <0.05 was taken as significant. All tests were two-tailed and performed by the SPSS for Windows 2011 (Version 19.0, IBM, WA, USA) and S-PLUS (version 8.0, 2007, Insightful Corp, Seattle, WA, USA).
RESULTS

Study population and outcomes
of the 1599 patients admitted to the ICU during the study period, 1446 (90.4%) survived to their first ICU discharge, 106 (6.6%) patients were re-admitted to the ICU after discharge during the same hospitalisation and 103 (6.4%) died unexpectedly after their first ICU discharge. Another 75 patients (4.7%) died after hospital discharge as of 31 october 2011 ( Figure 1 ). A total of 253 patients (17.5%) had either unexpected re-admission during the same hospitalisation or post-ICU mortality before 31 october 2011. Eosinophil count was available on the day of ICU discharge in 1394 patients (96.4%) and eosinopenia occurred in 130 patients (9.7%) ( Figure 2 ).
Characteristics of the patients who were re-admitted to ICU and risk factors for ICU re-admission
The median time between the first ICU discharge and re-admission was seven days (interquartile range . Those who were subsequently re-admitted to ICU were slightly older (53 vs 50 years old), more likely to be initially admitted to the ICU because of sepsis or multiple trauma, and had a more severe acute illness (APACHE II predicted mortality 20 vs 17%, P=0.02) than those who did not have ICU re-admission. Eosinopenia at ICU discharge was significantly more common among those who were re-admitted to the ICU (18.6 vs 8.6%; P=0.002) than those who did not have ICU re-admission (Table 1 ). In the multivariate logistic regression analysis, only eosinopenia (odds ratio 2.50, 95% CI 1.38-4.50; P=0.002) and diabetes mellitus requiring insulin (odds ratio 2.97, 95% CI 1.33-6.65; P=0.008) were significantly associated with an increased risk of ICU re-admission ( Table 2 ). Including CRP concentrations at ICU discharge in the final multivariate model also did not change the direction and magnitude of the association between eosinopenia and risk of ICU re-admission (oR 2.99, 95% CI 1.47-6.07; P=0.002). 
Risk factors for mortality after first ICU discharge
Those who died after ICU discharge were significantly older (65 vs 48 years old), more likely to be initially admitted to ICU because of sepsis (17.4 vs 4.0%), had a more severe acute illness and also more co-existing medical illnesses, including diabetes mellitus requiring insulin, cirrhosis, chronic renal failure requiring dialysis, metastatic cancer and hematological malignancies (Table 3) . Eosinopenia (22.5 vs 7.5%, P=0.001) and a higher CRP concentration (119 vs 101 mg/l, P=0.037) were more common among those who died after ICU discharge than those who survived until the date of censor for survival.
In the multivariate Cox regression analysis, eosinopenia (hazard ratio 2.65, 95% CI 1.77-3.98; P=0.001) remained associated with an increased risk of unexpected mortality after adjusting for other covariates (Table 4, Figure 3 ). other important factors in determining the medium-term survival were age, severity of acute illness as measured by the APACHE II predicted mortality, diabetes mellitus requiring insulin, chronic respiratory disease, haematological malignancies and metastatic cancer. Eosinopenia at ICU discharge explained about 8.4% of the variability and was the third most important factor-after age (13%) and diabetes mellitus (9.9%)-in explaining the variability in survival after ICU discharge ( Figure  4 ). Including CRP concentrations at ICU discharge in the final multivariable Cox model also did not change the direction and magnitude of the association between eosinopenia and risk of mortality after ICU discharge (hazard ratio 3.1, 95% CI 1.9-5.0; P=0.001). CRP at ICU discharge was, however, not associated with an increased risk of mortality after adjusting for all covariates in the final model (hazard ratio 1.0, 95% CI 0.9-1.1; P=0.478).
Eosinophil count as a continuous predictor for either unplanned re-admission or mortality after ICU discharge
When eosinophil count was modelled as a continuous predictor, the risk of either unexpected re-admission or post-ICU mortality only increased significantly when the eosinophil counts were less than 0.1×10 9 /l ( Figure 5 ), suggesting that only Chi-square test minus degrees of freedom Figure 5 : Non-linear relationship between absolute eosinophil count (×10 9 /l) at ICU discharge and odds of having unplanned ICU re-admission during the same hospitalisation or mortality after ICU discharge. Dotted lines signify 95% confidence interval. ICU=intensive care unit. log odds of either unplanned readmission or mortality after ICU discharge eosinopenia, but not eosinophilia, was important in predicting adverse outcomes after ICU discharge. The sensitivity, specificity, positive predictive value and negative predictive value of eosinopenia to predict unexpected re-admission, mortality or either of these adverse events are described in Table 5 .
DISCUSSIoN
In this study we assessed the incidence of eosinopenia during the recovery phase of critical illness and showed that eosinopenia was not rare (9.7%) and was associated with an increased risk of unexpected ICU re-admission and mortality after ICU discharge. This result has some clinical implications and requires careful consideration.
First, unexpected ICU re-admission has a significant attributable effect on morbidity and mortality of critically ill patients 5 . Many strategies have been suggested to reduce inappropriate ICU discharges and, at the same time, avoid prolonging unnecessary ICU stay. Although complicated prognostic models to predict risk of unexpected ICU re-admission or mortality are available [12] [13] [14] , their clinical applicability for decision-making at the bedside is limited by their complexity. Thus, it will be attractive to clinicians to have some readily available tests to stratify their patients' subsequent risk of adverse outcomes at the time of ICU discharge. our results suggested that the utility of eosinopenia lies in its high 'negative predictive value'. Although an absence of eosinopenia might be reassuring to clinicians about a lower risk of unexpected re-admission or mortality after ICU discharge, the presence of eosinopenia was not as useful due to its low positive predictive value. We also noted that eosinophil counts did not have a linear relationship with the risk of adverse outcomes after ICU discharge. In fact, only eosinopenia, defined by eosinophil count <0.01×10 9 /l, was associated with an increased risk of adverse outcomes after ICU discharge. As such, the absolute eosinophil count at ICU discharge is not useful and only eosinopenia, as a dichotomised variable, may be useful as an adjunct to other clinical predictors to predict adverse outcomes after ICU discharge.
Second, recent studies suggested that CRP at the time of ICU discharge may be useful to stratify a patient's risk of adverse outcomes after ICU discharge 1, 4, 11, 27, 28 . However, the association between a high CRP and an increased risk of adverse outcomes after ICU discharge is by no means consistent in all published studies 29, 30 . Although CRP concentrations at ICU discharge were associated with a higher risk of mortality in the univariate analysis in this study, this association was no longer significant after eosinopenia was included in the multivariate analysis. This could be due to the fact that only 52% of our patients had CRP measured within 24 hours of ICU discharge, or perhaps, eosinophil count is a more rapid biomarker than CRP in response to changes in inflammation or infection. In an animal model of infection, eosinophil counts reduced to 80% of the trough level within six hours of initiation of infection and returned to a normal level within 12 hours after commencement of appropriate antibiotic 31 . The dynamic response of eosinophil count to infection and resolution of inflammation compares favourably to the relatively long half-life of CRP (~19 hours) 32 , especially important when the ICU length-of-stay is shorter than a few half-lives of the biomarker concentrations. Large observational studies comparing predictive ability of different inflammatory markers for adverse outcomes after ICU discharge are, however, needed to confirm whether eosinopenia is a better biomarker than CRP or other inflammatory markers in differentiating adverse events after ICU discharge by having a larger area under the receiver operating characteristic curve, and whether they can be used together to facilitate ICU discharge.
Third, we could not confirm nocturnal discharge as a risk factor for adverse outcomes after ICU discharge in this study. This may be due to the fact that the study centre has a consultant intensivist working in the ICU until late at night (8.00 am-11.00 pm) during the weekdays and patients are often discharged to the high dependency unit instead of the general hospital wards at night. The last consideration is the limitations of this study. First, it has to be emphasised that eosinopenia is a non-specific marker of inflammation or infection. Similar to all non-specific biomarkers, the diagnostic or prognostic ability of eosinopenia is expected to vary substantially depending on the pre-test probability of the event in the cohort of patients 33 . As such, we would expect eosinopenia to perform better as a predictor of adverse outcomes after ICU discharge when such events are relatively uncommon (e.g. <10%) ( Figure 6 ). Second, this was a single-centre study and hence validation of our results by other centres is essential to confirm the external validity of our findings. Third, eosinopenia can be induced by a number of factors including sepsis, therapy with corticosteroids and catecholamines, and physiological stress [16] [17] [18] . Systemic corticosteroids are not routinely used for most patients with septic shock in the study centre. Whether eosinopenia is also useful to predict adverse outcomes in ICUs where corticosteroids are frequently used remains uncertain. Finally, we did not have post-mortem results for most of the deaths included in this study. Whether eosinopenia at ICU discharge is only useful to predict deaths or re-admissions due to occult infections 1,4 , but not other causes such as venous thromboembolism, remains uncertain 7 .
CoNCLUSIoNS
Eosinopenia was not rare during the recovery phase of critical illness and was associated with an increased risk of unexpected re-admission and mortality after ICU discharge, suggesting that latent inflammation or incomplete recovery from infection at ICU discharge may be associated with worse outcomes after critical illness. The clinical utility of eosinopenia relies mainly on its high negative predictive value: an absence of eosinopenia at ICU discharge is reassuring for a reduced risk of adverse outcomes after ICU discharge. Further studies on the prognostic value of eosinopenia at ICU discharge are needed to confirm the results of this preliminary study. Figure 6 : The relationship between post-test probability of having either unexpected re-admission or mortality after intensive care unit discharge in patients who had eosinopenia and the prevalence of these events. The relative change in odds is greatest when the prevalence of adverse outcome is low (e.g. <10%). 
